Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers
about
Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker AssessmentSwitching off malignant mesothelioma: exploiting the hypoxic microenvironmentAssessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.Common genetic variants and modification of penetrance of BRCA2-associated breast cancerPhysical confirmation and mapping of overlapping rat mammary carcinoma susceptibility QTLs, Mcs2 and Mcs6The proliferating role of insulin and insulin-like growth factors in cancer.Suppression of Homologous Recombination by insulin-like growth factor-1 inhibition sensitizes cancer cells to PARP inhibitorsGenetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriersInsulin-like growth factor-1 signaling in renal cell carcinomaNon-iterative, regression-based estimation of haplotype associations with censored survival outcomes.A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk.Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancerAssociation between IRS1 Gene Polymorphism and Autism Spectrum Disorder: A Pilot Case-Control Study in Korean Males.Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers.Diabetes, gestational diabetes and the risk of cancer in women: epidemiologic evidence and possible biologic mechanisms.Unravelling modifiers of breast and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: update on genetic modifiers.Association between insulin receptor substrate 1 Gly972Arg polymorphism and cancer risk.Methylation profiling in individuals with uniparental disomy identifies novel differentially methylated regions on chromosome 15Involvement of IGF-1R regulation by miR-515-5p modifies breast cancer risk among BRCA1 carriers.Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen.IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer.Altered expression of telomere-associated genes in leukocytes among BRCA1 and BRCA2 carriers.Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer.Elucidating the novel BRCA1 function as a non-genomic metabolic restraint in ER-positive breast cancer cell linesChinese herbal products and the reduction of risk of breast cancer among females with type 2 diabetes in Taiwan: A case-control study
P2860
Q26798408-B5E248CF-7494-48DD-B3D9-6F7EB4A165E0Q29248727-26982A17-925F-4959-B114-07D2EA2EF5DFQ30277151-5F52AE5B-DF47-4062-BB1A-792E2A9F94B5Q33742096-12D70090-5990-490E-8708-158C2A016878Q33916825-38098799-2100-421A-B5E6-6128F00D44D6Q34172625-455F9C60-DF31-4D79-85F7-575BC853A6B1Q35824908-F08D55F4-A99A-4668-A100-F1DB0D0F43ECQ35961713-389992EA-77D8-4D39-8D2D-9E8EFCEF7FB9Q36074111-9FAE7DF1-CDEF-4738-844C-A79AC7BE0D88Q36090710-FC028BD6-82B6-45E0-AA11-11EF38C19762Q36152991-84EBE495-8583-4CAE-9661-66CD354362DFQ36839777-5B531A13-AE7B-43B4-8146-97030AA101D3Q36978703-B397D3B1-D9B8-4AC1-8D15-142E93516B85Q37069878-3F3A2BC5-6C62-4392-A979-9B037B35D0EAQ37209924-C6AB6084-847B-42E1-AB91-005304BAD647Q37834134-D57351DC-095F-4A39-BD81-CBACC8424C48Q37853559-B0F57870-9717-4A4C-B911-17E1F6FDDA9CQ37996438-4211965B-3559-4EFF-8636-D300A61EBA25Q38109537-34DC888C-CDA4-45D6-9D3B-70DE14306247Q42008490-49E6DC8A-72B8-4C3D-9E0C-A50C5B7D5D10Q44477999-A96AE7A7-01C3-4A62-BE66-5752A665A930Q46098680-A4AE87DE-83DB-46C4-ADB3-374C2B101D2AQ46334218-841E8F31-284B-464A-B3B4-EBC52E0DE3E8Q47782009-EEAD6BD0-05AA-4384-B715-9E844371BBCEQ54223961-D7D84BEF-E39A-4BCD-AD77-2685A208CA5BQ57493678-5C00A31D-B94D-404B-82AC-4CED1C9D25FAQ58802069-F5018D31-2A5A-45F0-B6F5-FA1FD132CC4D
P2860
Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic variation in insulin-l ...... among BRCA1 and BRCA2 carriers
@en
Genetic variation in insulin-l ...... mong BRCA1 and BRCA2 carriers.
@nl
type
label
Genetic variation in insulin-l ...... among BRCA1 and BRCA2 carriers
@en
Genetic variation in insulin-l ...... mong BRCA1 and BRCA2 carriers.
@nl
prefLabel
Genetic variation in insulin-l ...... among BRCA1 and BRCA2 carriers
@en
Genetic variation in insulin-l ...... mong BRCA1 and BRCA2 carriers.
@nl
P2093
P2860
P50
P356
P1476
Genetic variation in insulin-l ...... among BRCA1 and BRCA2 carriers
@en
P2093
Andrew K Godwin
Christian F Singer
Daniel L Gillen
Gail Tomlinson
Georg Pfeiler
Henry T Lynch
Joanne L Blum
Judy E Garber
Mary B Daly
Nadine Tung
P2860
P2888
P356
10.1186/BCR2414
P50
P577
2009-01-01T00:00:00Z
P5875
P6179
1025906578